Biopharmaceutical co. focused on the development & manufacturing of biosimilar medicines
Active 2021–2022.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2022 | MEHLMAN CONSULTING, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Termination (No Activity) |
— | |
| 2022 | MEHLMAN CONSULTING, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report (No Activity) |
— | |
| 2021 | MEHLMAN CONSULTING, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$30,000 | |
| 2021 | MEHLMAN CONSULTING, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$50,000 | |
| 2021 | MEHLMAN CONSULTING, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$40,000 | |
| 2021 | MEHLMAN CONSULTING, INC. |
2nd Quarter (Apr 1 - June 30) Registration |
— |
| Firm | Filings | Amount |
|---|---|---|
| MEHLMAN CONSULTING, INC. | 6 | $120,000 |
| Issue | Activities |
|---|---|
| Copyright/Patent/Trademark | 4 |
| Health Issues | 4 |